Dossier
Heritage Pharmaceuticals
Coverage of Heritage Pharmaceuticals in the Nexus archive.
- STAT+: Sandoz to pay $478.5 million to settle price-fixing allegations in long-running battle with states
Sandoz agreed to pay $478.5 million to settle allegations of price-fixing generic drugs, including $400 million over seven years to states and $28.5 million to resellers. The company denied wrongdoing as part of a long-running legal battle with states and resellers over inflated drug prices.